Treatment landscape for elderly acute myeloid leukemia (AML) patients
MURANO: safety and efficacy data presented at ASH 2017
Is inotuzumab ozogamicin with low-dose chemotherapy effective in treating ALL in elderly patients?
ECHELON-1 trial data from ASH 2017: controversies and clinical translation
Big data on efficacy and toxicity levels for ibrutinib in CLL